Department of Periodontology, Semmelweis University, Budapest, Hungary.
J Periodontol. 2013 Nov;84(11):1546-55. doi: 10.1902/jop.2013.120501. Epub 2013 Jan 17.
Regenerative periodontal surgery using the combination of enamel matrix derivative (EMD) and natural bone mineral (NBM) with and without addition of platelet-rich plasma (PRP) has been shown to result in substantial clinical improvements, but the long-term effects of this combination are unknown.
The goal of this study was to evaluate the long-term (5-year) outcomes after regenerative surgery of deep intrabony defects with either EMD + NBM + PRP or EMD + NBM. Twenty-four patients were included. In each patient, one intrabony defect was randomly treated with either EMD + NBM + PRP or EMD + NBM. Clinical parameters were evaluated at baseline and 1 and 5 years after treatment. The primary outcome variable was clinical attachment level (CAL).
The sites treated with EMD + NBM + PRP demonstrated a mean CAL change from 10.5 ± 1.6 to 6.0 ± 1.7 mm (P <0.001) at 1 year and 6.2 ± 1.5 mm (P <0.001) at 5 years. EMD + NBM-treated defects showed a mean CAL change from 10.6 ± 1.7 to 6.1 ± 1.5 mm (P <0.001) at 1 year and 6.3 ± 1.4 mm (P <0.001) at 5 years. At 1 year, a CAL gain of ≥4 mm was measured in 83% (10 of 12) of the defects treated with EMD + NBM + PRP and in 100% (all 12) of the defects treated with EMD + NBM. Compared to baseline, in both groups at 5 years, a CAL gain of ≥4 mm was measured in 75% (nine of 12 in each group) of the defects. Four sites in the EMD + PRP + NBM group lost 1 mm of the CAL gained at 1 year. In the EMD + NBM group, one defect lost 2 mm and four other defects lost 1 mm of the CAL gained at 1 year. No statistically significant differences in any of the investigated parameters were observed between the two groups.
Within their limits, the present results indicate that: 1) the clinical outcomes obtained with both treatments can be maintained up to a period of 5 years; and 2) the use of PRP does not appear to improve the results obtained with EMD + NBM.
使用 enamel matrix derivative(EMD)和 natural bone mineral(NBM)联合或不联合 platelet-rich plasma(PRP)进行再生牙周手术已被证明可显著改善临床效果,但这种联合治疗的长期效果尚不清楚。
本研究的目的是评估 EMD + NBM + PRP 或 EMD + NBM 再生手术治疗深部骨内缺损 5 年的长期(5 年)效果。共纳入 24 例患者。在每位患者中,随机将一个骨内缺损分别用 EMD + NBM + PRP 或 EMD + NBM 进行治疗。治疗后 1 年和 5 年分别对临床参数进行评估。主要观察变量为临床附着水平(CAL)。
接受 EMD + NBM + PRP 治疗的部位在 1 年时的平均 CAL 变化为 10.5 ± 1.6 至 6.0 ± 1.7 mm(P <0.001),在 5 年时为 6.2 ± 1.5 mm(P <0.001)。接受 EMD + NBM 治疗的缺损在 1 年时的平均 CAL 变化为 10.6 ± 1.7 至 6.1 ± 1.5 mm(P <0.001),在 5 年时为 6.3 ± 1.4 mm(P <0.001)。在 1 年时,接受 EMD + NBM + PRP 治疗的 12 个缺损中有 83%(10/12)和接受 EMD + NBM 治疗的 12 个缺损中有 100%(12/12)获得了≥4 mm 的 CAL 增益。与基线相比,在第 5 年时,两组中均有 75%(每组 9/12)的缺损获得了≥4 mm 的 CAL 增益。EMD + PRP + NBM 组中有 4 个部位在第 1 年时获得的 CAL 丢失了 1 mm。在 EMD + NBM 组中,一个缺损丢失了 2 mm,四个其他缺损丢失了 1 mm。两组间的任何调查参数均无统计学差异。
在其限制范围内,目前的结果表明:1)两种治疗方法获得的临床效果可以维持长达 5 年;2)使用 PRP 似乎并不能改善 EMD + NBM 治疗的效果。